Stock listing
BOATS:ARVN Arvinas, Inc. Stock
US listing (BOATS) of Arvinas, Inc. · home listing NASDAQ:ARVN
Follow Arvinas, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ARVN
$7.45 USD +0.14 (+1.9%)
Close on Oct 27, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ARVN
- Day range
- $7.22 – $7.53 USDOct 27, 2026
- Volume
- 800,824 sharesOct 27, 2026
- Market cap
- $480.7M USDAt the close on Oct 27, 2026 · price × 64.52M shares outstanding
- 52-week range
- $6.74 – $14.51 USDLowest and highest trades, Oct 28, 2025 – Oct 27, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ARVN · Home | $7.45 USD | +0.14 (+1.9%) | 800,824 | $7.31 | $7.525 | $7.22 | $7.31 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 27, 2026 – Oct 27, 2026 · NASDAQ:ARVN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.45 | +0.14 | +1.9% | $7.31 | $7.525 | $7.22 | 800,824 | |
| $7.31 | +0.01 | +0.1% | $7.32 | $7.405 | $7.23 | 724,837 | |
| $7.30 | -0.42 | -5.4% | $7.70 | $7.70 | $7.20 | 651,573 | |
| $7.72 | +0.165 | +2.2% | $7.53 | $7.74 | $7.40 | 620,196 | |
| $7.555 | -0.105 | -1.4% | $7.62 | $7.79 | $7.54 | 653,595 | |
| $7.66 | +0.40 | +5.5% | $7.28 | $7.74 | $7.28 | 540,851 | |
| $7.26 | +0.29 | +4.2% | $7.06 | $7.29 | $6.95 | 795,636 | |
| $6.97 | -0.19 | -2.7% | $7.16 | $7.30 | $6.93 | 760,800 | |
| $7.16 | +0.34 | +5.0% | $6.88 | $7.18 | $6.83 | 605,900 | |
| $6.82 | -0.02 | -0.3% | $6.77 | $6.96 | $6.74 | 857,000 | |
| $6.84 | -0.61 | -8.2% | $7.54 | $7.54 | $6.80 | 852,900 | |
| $7.45 | -0.19 | -2.5% | $7.73 | $7.73 | $7.44 | 502,600 | |
| $7.64 | +0.13 | +1.7% | $7.46 | $7.74 | $7.46 | 560,000 | |
| $7.51 | +0.06 | +0.8% | $7.37 | $7.55 | $7.25 | 1,016,600 | |
| $7.45 | +0.14 | +1.9% | $7.25 | $7.46 | $7.22 | 601,800 | |
| $7.31 | -0.15 | -2.0% | $7.49 | $7.49 | $7.275 | 585,799 | |
| $7.46 | +0.05 | +0.7% | $7.46 | $7.505 | $7.22 | 628,531 | |
| $7.41 | -0.02 | -0.3% | $7.51 | $7.52 | $7.30 | 585,100 | |
| $7.43 | -0.31 | -4.0% | $7.74 | $7.82 | $7.43 | 807,200 | |
| $7.74 | +0.24 | +3.2% | $7.55 | $8.04 | $7.44 | 1,061,000 | |
| $7.50 | -0.01 | -0.1% | $7.49 | $7.52 | $7.36 | 496,000 | |
| $7.51 | -0.08 | -1.1% | $7.54 | $7.57 | $7.38 | 512,100 | |
| $7.59 | -0.20 | -2.6% | $7.78 | $7.81 | $7.54 | 713,400 | |
| $7.79 | -0.04 | -0.5% | $7.81 | $7.82 | $7.39 | 1,218,000 | |
| $7.83 | -0.68 | -8.0% | $8.60 | $8.64 | $7.82 | 761,300 | |
| $8.51 | +0.21 | +2.5% | $8.37 | $8.57 | $8.30 | 685,400 | |
| $8.30 | +0.01 | +0.1% | $8.37 | $8.44 | $8.21 | 639,800 | |
| $8.29 | -0.02 | -0.2% | $8.29 | $8.35 | $8.19 | 1,775,900 | |
| $8.31 | +0.15 | +1.8% | $8.29 | $8.46 | $8.17 | 533,100 | |
| $8.16 | -0.10 | -1.2% | $8.31 | $8.33 | $8.05 | 742,600 | |
| $8.26 | -0.14 | -1.7% | $8.34 | $8.39 | $8.09 | 2,523,100 | |
| $8.40 | -0.05 | -0.6% | $8.49 | $8.70 | $8.39 | 1,471,600 | |
| $8.45 | -0.26 | -3.0% | $8.82 | $8.92 | $8.37 | 908,600 | |
| $8.71 | -0.05 | -0.6% | $8.67 | $8.78 | $8.47 | 776,700 | |
| $8.76 | -0.32 | -3.5% | $9.09 | $9.10 | $8.75 | 736,000 | |
| $9.08 | -0.31 | -3.3% | $9.23 | $9.34 | $8.97 | 570,700 | |
| $9.39 | +0.08 | +0.9% | $9.31 | $9.46 | $9.22 | 449,300 | |
| $9.31 | -0.28 | -2.9% | $9.68 | $9.69 | $9.21 | 501,400 | |
| $9.59 | +0.31 | +3.3% | $9.28 | $9.64 | $9.27 | 548,800 | |
| $9.28 | +0.08 | +0.9% | $9.14 | $9.30 | $9.06 | 491,100 | |
| $9.20 | +0.02 | +0.2% | $9.12 | $9.27 | $8.96 | 659,700 | |
| $9.18 | -0.06 | -0.6% | $9.17 | $9.24 | $9.03 | 600,300 | |
| $9.24 | -0.08 | -0.9% | $9.27 | $9.43 | $9.15 | 527,000 | |
| $9.32 | -0.28 | -2.9% | $9.53 | $9.55 | $9.28 | 532,600 | |
| $9.60 | +0.26 | +2.8% | $9.39 | $9.74 | $9.39 | 530,300 | |
| $9.34 | -0.03 | -0.3% | $9.28 | $9.39 | $9.06 | 500,400 | |
| $9.37 | +0.34 | +3.8% | $9.02 | $9.39 | $9.00 | 951,800 | |
| $9.03 | -0.65 | -6.7% | $9.55 | $9.63 | $8.97 | 601,500 | |
| $9.68 | +0.42 | +4.5% | $9.44 | $9.69 | $9.44 | 494,200 | |
| $9.26 | +0.06 | +0.7% | $9.19 | $9.33 | $9.10 | 554,700 | |
| $9.20 | +0.23 | +2.6% | $8.91 | $9.26 | $8.89 | 584,000 | |
| $8.97 | -0.04 | -0.4% | $8.91 | $8.98 | $8.72 | 461,100 | |
| $9.01 | +0.14 | +1.6% | $8.91 | $9.09 | $8.86 | 939,100 | |
| $8.87 | -0.12 | -1.3% | $8.99 | $8.99 | $8.71 | 524,400 | |
| $8.99 | 0.00 | 0.0% | $8.99 | $9.115 | $8.86 | 572,103 | |
| $8.99 | +0.24 | +2.7% | $8.70 | $9.02 | $8.59 | 671,769 | |
| $8.75 | +0.07 | +0.8% | $8.81 | $8.98 | $8.64 | 1,218,200 | |
| $8.68 | +0.28 | +3.3% | $8.40 | $8.72 | $8.37 | 2,580,600 | |
| $8.40 | -0.60 | -6.7% | $8.82 | $8.91 | $8.21 | 1,571,500 | |
| $9.00 | +0.94 | +11.7% | $8.33 | $9.65 | $8.33 | 3,032,800 | |
| $8.06 | +0.03 | +0.4% | $8.10 | $8.17 | $7.92 | 716,800 | |
| $8.03 | -0.27 | -3.3% | $8.24 | $8.24 | $7.90 | 687,900 | |
| $8.30 | +0.08 | +1.0% | $8.11 | $8.31 | $8.10 | 549,700 | |
| $8.22 | +0.02 | +0.2% | $8.18 | $8.34 | $8.09 | 740,500 | |
| $8.20 | -0.02 | -0.2% | $8.26 | $8.32 | $8.02 | 551,900 | |
| $8.22 | +0.19 | +2.4% | $8.13 | $8.37 | $8.12 | 475,500 |
- Ticker
- BOATS:ARVN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Arvinas Announces Return of Early Career Researcher Award to Recognize Innovation in Targeted Protein Degradation
Latest earnings call · Aug 4, 2026
Arvinas (NASDAQ:ARVN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 56 slides
Calls
Replays
Arvinas (NASDAQ:ARVN) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 8:00 AM ET
Watch TranscriptArvinas (NASDAQ:ARVN) Q1 2026 Earnings Call
Tue, May 12, 2026 · 8:00 AM ET
Watch TranscriptArvinas (NASDAQ:ARVN) Q4 2025 Earnings Call
Tue, Feb 24, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026
Oct 27, 2026
Closed $7.45 (+1.9%) on Oct 27, 2026
Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease
Oct 7, 2026
Closed $7.45 (+1.9%) on Oct 7, 2026
Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®
Oct 1, 2026
Closed $7.41 (-0.3%) on Oct 2, 2026
Arvinas Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sep 29, 2026
Closed $7.74 (+3.2%) on Sep 30, 2026
Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company's First Immuno-Oncology Candidate
Sep 29, 2026
Closed $7.50 (-0.1%) on Sep 29, 2026
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 4, 2026
Closed $9.00 (+11.7%) on Aug 4, 2026
Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026
Jul 28, 2026
Closed $8.20 (-0.2%) on Jul 28, 2026
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
Jun 4, 2026
Closed $7.74 (+0.5%) on Jun 4, 2026
Arvinas Employees Give Back During Company-wide Impact Day
May 18, 2026
Closed $8.78 (-3.3%) on May 18, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 56 slides · August 2026
Jefferies Global Healthcare Conference 2026
Conference · 8 slides · Jun 2, 2026
Q4 2025 Earnings Presentation
Earnings · 74 slides · Feb 24, 2026
Q2 2025 Earnings Presentation
Earnings · 70 slides · Aug 6, 2025
Arvinas, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 167 in all · newest Oct 27, 2026 · oldest 2019
- Calls
- 8 calls with a replay · 8 with a transcript · latest Aug 4, 2026
- Decks
- 19 decks · latest August 2026
Where Arvinas, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ARVN · Home listing | NASDAQ | United States | USD |
| BOATS:ARVN · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Arvinas, Inc.